Sohanya Cheng
Corporate Officer/Principal chez KARYOPHARM THERAPEUTICS INC.
Fortune : 75 137 $ au 30/04/2024
Profil
Sohanya Cheng is currently the Chief Commercial Officer at Karyopharm Therapeutics, Inc. Prior to this, she held the position of Executive Director, Head-Marketing & Sales at Amgen, Inc. from 2018 to 2020.
She also served as the VP, Head-Marketing & Corporate Affairs at Arrowhead Pharmaceuticals, Inc. in 2020.
Ms. Cheng completed her undergraduate and graduate studies at the University of Cambridge and holds an MBA from MIT Sloan School of Management.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
29/03/2024 | 70 884 ( 0,06% ) | 75 137 $ | 30/04/2024 |
Postes actifs de Sohanya Cheng
Sociétés | Poste | Début |
---|---|---|
KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | 10/01/2022 |
Anciens postes connus de Sohanya Cheng
Sociétés | Poste | Fin |
---|---|---|
ARROWHEAD PHARMACEUTICALS, INC. | Sales & Marketing | 01/12/2020 |
AMGEN INC. | Sales & Marketing | 01/08/2020 |
Formation de Sohanya Cheng
MIT Sloan School of Management | Masters Business Admin |
University of Cambridge | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 3 |
---|---|
KARYOPHARM THERAPEUTICS INC. | Health Technology |
ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
AMGEN INC. | Health Technology |